{"abstract":"Lyndra Therapeutics has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.","action":"Notice of application.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/02/25/2022-04061.html","cfr_references":[],"citation":"87 FR 10823","comment_url":null,"comments_close_on":"2022-03-28","correction_of":null,"corrections":[],"dates":"Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 28, 2022. Such persons may also file a written request for a hearing on the application on or before March 28, 2022.","disposition_notes":null,"docket_ids":["Docket No. DEA-965"],"dockets":[],"document_number":"2022-04061","effective_on":null,"end_page":10823,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/02/25/2022-04061.xml","html_url":"https://www.federalregister.gov/documents/2022/02/25/2022-04061/importer-of-controlled-substances-application-lyndra-therapeutics","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-04061?publication_date=2022-02-25","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-02-25/2022-04061/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":80,"last_updated":"2026-04-04 18:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-02-25/pdf/2022-04061.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-04061.pdf?1645710357","publication_date":"2022-02-25","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/02/25/2022-04061.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T17:26:17Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":10823,"subtype":null,"title":"Importer of Controlled Substances Application: Lyndra Therapeutics","toc_doc":"Lyndra Therapeutics","toc_subject":"Importer of Controlled Substances Application:\n","topics":[],"type":"Notice","volume":87}